🇺🇸 FDA
Pipeline program

SYNTOCINON 40 i.e./ml pršilo za nos, raztopina, Oxytocin Placebo

OXY-APS

Phase 2 small_molecule active

Quick answer

SYNTOCINON 40 i.e./ml pršilo za nos, raztopina, Oxytocin Placebo for schizophrenia or other primary psychotic disorders (SSD) is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Institut für biomedizinische Analytik NMR-Imaging GmbH
Indication
schizophrenia or other primary psychotic disorders (SSD)
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials